FDA Inspection 1018903 — Dottikon Exclusive Synthesis AG

Dottikon Exclusive Synthesis AG — FEI 3002806909

The FDA completed an inspection of Dottikon Exclusive Synthesis AG on July 14, 2017 in Dottikon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Dottikon (Switzerland)